Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Antimetabolites, Antineoplastic
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Antimetabolites, Antineoplastic
Tree Number(s)
D27.505.519.186.144
D27.505.954.248.144
D27.888.569.042.030
Unique ID
D000964
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000964
Annotation
TN 4: relation to
ANTINEOPLASTIC AGENTS
Scope Note
Antimetabolites that are useful in cancer chemotherapy.
Entry Version
ANTIMETAB ANTINEOPL
Entry Term(s)
Antineoplastic Antimetabolites
NLM Classification #
QV 269
Previous Indexing
Antineoplastic Agents (1966-1974)
Public MeSH Note
75
History Note
75
Date Established
1975/09/01
Date of Entry
1999/01/01
Revision Date
2014/06/25
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Antimetabolites [D27.505.519.186]
Hypolipidemic Agents [D27.505.519.186.071]
Antimetabolites, Antineoplastic [D27.505.519.186.144]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Antineoplastic Agents [D27.505.954.248]
Angiogenesis Inhibitors [D27.505.954.248.025]
Antibiotics, Antineoplastic [D27.505.954.248.106]
Anticarcinogenic Agents [D27.505.954.248.125]
Antimetabolites, Antineoplastic [D27.505.954.248.144]
Antimitotic Agents [D27.505.954.248.147]
Antineoplastic Agents, Alkylating [D27.505.954.248.150]
Antineoplastic Agents, Hormonal [D27.505.954.248.169]
Antineoplastic Agents, Phytogenic [D27.505.954.248.179]
Antineoplastic Agents, Immunological [D27.505.954.248.384]
MTOR Inhibitors [D27.505.954.248.538]
Myeloablative Agonists [D27.505.954.248.589]
Poly(ADP-ribose) Polymerase Inhibitors [D27.505.954.248.692]
Topoisomerase Inhibitors [D27.505.954.248.794]
Chemical Actions and Uses [D27]
Toxic Actions [D27.888]
Noxae [D27.888.569]
Antimetabolites [D27.888.569.042]
Antimetabolites, Antineoplastic [D27.888.569.042.030]
Expand All
Collapse All
Antimetabolites, Antineoplastic
Preferred
Concept UI
M0001471
Scope Note
Antimetabolites that are useful in cancer chemotherapy.
Terms
Antimetabolites, Antineoplastic
Preferred Term
Term UI
T002958
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1975)
Antineoplastic Antimetabolites
Term UI
T002957
Date
01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
page delivered in 0.164s